Renah Hightower
Physician Assistant · Dublin, GANPI 1285039396
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 315 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,458, 4.3 times the $573 reported in 2021. Among physician assistant clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 315 payments — averaging $21.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Sanofi$992
- GSK$873
- Regeneron Healthcare Solutions, Inc.$647
- AbbVie$473
- Grifols USA, LLC$352
- plus $2K from 19 others
What the payments were for
- Food & beverage$6,832100%
- Education$340%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 55 | $1,110 |
| Sanofi | 38 | $992 |
| GSK | 53 | $873 |
| Regeneron Healthcare Solutions, Inc. | 34 | $647 |
| AbbVie | 11 | $473 |
| Grifols USA, LLC | 16 | $352 |
| Octapharma USA, Inc. | 11 | $343 |
| Genentech USA, Inc. | 15 | $319 |
| CSL Behring | 13 | $294 |
| Amgen | 13 | $286 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $212 |
| Novartis | 8 | $200 |
| Biocryst US Sales Co., LLC | 5 | $102 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $91 |
| Boehringer Ingelheim | 5 | $83 |
| Teva Pharmaceuticals USA, Inc. | 5 | $78 |
| LEO Pharma Inc. | 4 | $78 |
| Pfizer | 3 | $72 |
| Hikma Pharmaceuticals USA | 4 | $69 |
| Kaleo, Inc. | 3 | $59 |
| Lundbeck LLC | 2 | $41 |
| Blueprint Medicines Corporation | 1 | $26 |
| Optinose US, Inc. | 1 | $24 |
| Merck | 1 | $21 |
| Dermavant Sciences, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,866 in reported general payments places this provider in the 90th percentile of 3,581 physician assistant providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 21 | $118,130 |
| NucalaMepolizumab | 29 | $105,559 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 28 | $22,901 |
| Breo ElliptaFluticasone/Vilanterol | 25 | $11,969 |
| Spiriva RespimatTiotropium Bromide | 14 | $10,146 |
| Epinephrine | 22 | $5,771 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 21 | $4,313 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $4,238 |
| Ipratropium Bromide | 63 | $3,028 |
| Azelastine Hcl | 96 | $1,767 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 11 | $1,619 |
| Montelukast Sodium | 87 | $737 |
| Fluticasone Propionate | 71 | $691 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $368 |
| Triamcinolone Acetonide | 16 | $222 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKNucala, Trelegy Ellipta, Breo Ellipta | $873 | $140,42982 claims |
| Boehringer IngelheimSpiriva Respimat | $83 | $10,14614 claims |
| Hikma Pharmaceuticals USAEpinephrine | $69 | $5,77122 claims |
| AstraZenecaSymbicort | $1,110 | $4,23816 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,581 physician assistant providers in Georgia.
Other physician assistant in Dublin
- Douglas DiruggieroCartersville$1.3M
- Jennifer CobbsAtlanta$1M
- A BrunnerStockbridge$1M
- Joseph LangshawCalhoun$879K
- Alison MoeAtlanta$410K
- Maggie SchreckAtlanta$389K
- Lisa HillMarietta$190K
- Laura BishopBrunswick$103K
- Jaime AckermanAtlanta$84K
- Richard BurrellBrunswick$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.